This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: ETH Zurich. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations of Inventor Sai Reddy
Introduction
Sai Reddy is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of mammalian cell lines for protein production. With a total of 2 patents, his work is paving the way for advancements in protein engineering.
Latest Patents
One of Sai Reddy's latest patents focuses on a method for generating a mammalian cell line. This method involves several steps, including providing a plurality of mammalian B cells that contain a transgenic genomic DNA sequence encoding a marker protein. The process also includes replacing this sequence with a second transgenic DNA sequence that encodes a protein of interest. The B cells are then sorted based on the presence or absence of the marker protein, ultimately collecting those in which the marker protein is absent. This innovative approach has the potential to enhance protein production significantly.
Career Highlights
Sai Reddy is affiliated with ETH Zurich, a prestigious institution known for its cutting-edge research and innovation. His work at ETH Zurich has allowed him to explore various aspects of biotechnology and contribute to the scientific community through his patents.
Collaborations
Throughout his career, Sai Reddy has collaborated with esteemed colleagues, including William Kelton and Cristina Parola. These collaborations have enriched his research and expanded the impact of his innovations in the field.
Conclusion
Sai Reddy's contributions to biotechnology through his patents and research at ETH Zurich highlight his role as a leading inventor in the field. His innovative methods for protein production are set to influence future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
